Pilot survey of funders reveals challenges of tracking money; case studies show potential impact of this research on uptake and usability of drugs, diagnostics, vector control products, and vaccines. Read more...
-
MVI Portfolio
We strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity. -
Evaluation technology projects
We partner to develop and optimize new assays and challenge models and support reference and service laboratories. -
RTS,S
Ghana, Kenya, and Malawi to take part in WHO malaria vaccine pilot programme
